Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

Studies Investigating Co-morbidities Aggravating Heart Failure

Objective

Chronic heart failure (CHF) is a massive clinical, social and economic problem. Diabetes and obesity increase the risk of developing CHF. Cachexia is also an ominous sign. In 13 clinical and preclinical research projects, SICA-HF aims to investigate the impact of these co-morbidities in CHF patients at the clinical, vascular, cellular and molecular levels. SICA-HF will enrol >1600 patients with CHF, >300 patients with type 2 diabetes without CHF and >150 healthy control subjects. We will ensure that 50% of subjects are women and that group mean ages are similar. Clinical investigations using standardised protocols will focus on body composition, insulin resistance, exercise capacity, cardiopulmonary reflex patterns and peripheral blood flow. Subjects will be assessed at baseline, after 4-6 months, 16-18 months and at annual intervals thereafter. Outcome variables include morbidity and mortality and data on incidence and prevalence of type 2 diabetes, obesity and cachexia among CHF patients. A strength of this proposal is that clinical and preclinical researchers will study the same patients, as blood and tissue samples from patients being clinically evaluated will be sent to partner research laboratories. Such interaction is very rare in large-scale studies and allows integration of clinical and preclinical findings. The Central Blood and DNA Banks on the EU and the Russian side of the consortium permit validation of established and investigation of novel biomarkers. Pathophysiological pathways that are found to be important in the heart failure co-morbidity interaction will be further analysed mechanistically in in-vitro and in animal models. We aim to validate clinical study results in experimental settings towards the end of the project (year 3 & 4), particularly focusing on adipose tissue, skeletal muscle and (endothelial) progenitor cells. Our studies aim to enable developing tailored therapies for CHF patients with type 2 diabetes, obesity and cachexia.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP7-HEALTH-2009-single-stage
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CP-FP-SICA - Small/medium-scale focused research project for specific cooperation actions dedicated to international cooperation partner countries(SICA)

Coordinator

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
EU contribution
€ 1 567 329,30
Address
Chariteplatz 1
10117 Berlin
Germany

See on map

Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (12)

My booklet 0 0